INTRODUCTION
Curcumin[1,7-bis(4-hydroxy-3-ethoxyphenyl)-1,6-heptadiene-3,5-dione; diferuloylmethane], is the major constituent of the yellow spice, turmeric, derived from the rhizomes of Curcuma spp., which has been reported to have a variety of biological activities and pharmacological actions, such as anti-tumor, anti-inflammatory, anti-virus, anti-oxidation and anti-HIV, and low toxicity with promising clinical applications [1, 2] . However, curcumin is slightly absorbed in the gastrointestinal tract (GIT) due to its rapid metabolism by conjugation and reduction, and its oral bioavailability is very low (only 1 % in rats) [1, 2] . Pharmacokinetic properties of curcumin indicate that following oral administration, it is poorly absorbed [1] and only traces of the compound appear in the blood, while most of it is excreted in the faeces [1] . Piperine, the major alkaloidal component of Piper longum and Piper nigrum, has been reported to enhance the bioavailability of curcumin by 2000 % in human volunteers [1] .
In view of the potential pharmacological effects of curcumin and the possible role of piperine in the enhancement of its bioavailability, the simultaneous determination of these drugs in biological matrices can assist in monitoring their effectiveness, treatment compliance as well as help prevent adverse events and formulate optimum dosages.
Several methods have been developed to quantify curcumin and piperine individually, mainly using HPLC with UV [1] [2] [3] [4] [5] [6] [7] and MS detectors [1] . A reversed phase HPLC method has been reported for simultaneous determination of curcumin and piperine in human plasma [1] . However, the LOQs derived from the methods above were not low enough to enable pharmacokinetic study, and there has been no report of their simultaneous determination by HPLC-MS/MS. Due to ever increasing demands for assays with higher sensitivity, we have developed successfully a more sensitive liquid chromatography (LC)/tandem mass spectrometry (MS/MS) method with a lower limit of quantitation (LLOQ) of 1.00 ng/ml for curcumin and 0.50 ng/ml for piperine. 
EXPERIMENTAL

Chemicals and reagents
Reference standards of curcumin, piperine and diazepam(IS) with purity greater than 95% were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Sulfatase-free β-glucuronidase (type IX-A from Escherichia coli) was purchased from Sigma (St. Louis, MO). HPLC-grade acetonitrile, methyl t-butyl ether (MTBE), acetic acid, ammonium acetate and formic acid (99 %) were purchased from Tedia Company, Inc, Fairfield, USA.
LC-MS/MS conditions
An LC system (Waters Corporation, Milford, Massachusetts) consisting of an Acquity High Performance LC and electrospray ionization tandem mass spectrometer (ESI-MS/MS; Quattro Premier XE, Waters Corporation) was used. ESI-MS/MS was performed in the positive mode: capillary and cone voltages were 3.0 kV and 35 V, respectively; drying 
Standard solutions
Curcumin is not stable when pH is greater than 7.0 [1] . Therefore, its stock solution (50.0 μg/ml) was prepared in acetonitrileammonium acetate buffer (pH 4.5, 0.1M, 50:50, v/v). This solution was further diluted with the buffer to a series of working standard solutions (25.0, 125.0 and 1250.0 ng/ml, respectively). The stock solution of piperine was prepared in acetonitrile-water (50:50, v/v), and further diluted to give a series of working standards (25.0, 250.0, and 2500.0 ng/ml, respectively) in acetonitrile-water (50:50, v/v). The internal standard (IS, diazepam) stock solution (100.0 μg/ml) was prepared and further diluted to produce an IS working solution (1.0 μg/ml) using acetonitrile-water (50:50, v/v). All solutions were prepared in amber glassware and stored at 4 0 C. Due to stability considerations, all working standard solutions were prepared from the primary stock solution every month.
Preparation of calibration standards and test samples
Calibration standards were prepared by adding the appropriate volume of each working standard to human control plasma to obtain a final volume of 500 μl, giving seven calibration standards in the range 1.0 -100.0 ng/ml for curcumin and eight in the range 0.5 -800.0 ng/ml for piperine. Test samples were prepared in the same way as the calibration standard samples, with the test samples at final concentrations of 2.0, 10.0 and 80.0 ng/ml for curcumin, and 2.0, 30.0 and 500.0 ng/ml for piperine. All test samples were stored at -70 0 C until assayed.
Several aliquots of the three fractions were stored at −70 0 C as controls for future assays and used to check short-term stability under storage conditions. The analytes were considered stable at each concentration when the difference between the freshly prepared samples and the stability testing samples is not more than 15 % of the nominal concentration.
Sample preparation
The frozen plasma samples were thawed at room temperature, vortexed and centrifuged at 12000 rpm for 5 min prior to preparation; 500 μl of it was aliquoted into a 10-ml centrifuge tube and then 100 μl of phosphate buffer solution (75 mM; pH 6.8) with 1000U β-glucuronidase was added. The resulting solution was incubated to hydrolyze the curcumin conjugates at 37 0 C for 1 h. Following incubation, the samples were spiked with 100 μl of 0.1M ammonium acetate buffer (pH 4.5) and 30 μl of IS working solution and then extracted with methyl-t-butyl ether (5 ml) by rotating mixing. The organic extract was transferred to another clean 10 ml centrifuge tube and evaporated under a stream of nitrogen at 40 0 C. The dried residue was reconstituted in 100 μl mobile phase. The reconstituted samples were vortexed for 30 s and centrifuged at 3000 rpm for 5 min, then 10 µl of the supernatant was injected into the HPLC-MS/MS system.
Validation study
The methods were validated for selectivity, linearity, intra-and inter-day accuracy, and precision. LLOQ, matrix effect, stability of the analytes in biological matrix during short-and long-term storage and after three freezethaw cycles were also tested. Selectivity of the methods was investigated by analysing individual blank plasma samples of six donors for endogen interference with the analytes. Five calibration standards at LLOQ were used as reference samples.
The peak-area ratios of analyte/IS versus the nominal concentrations were plotted and a least-squares linear regression weighted by the reciprocal of the concentration (1/x) was applied to generate the calibration curve. Test sample concentrations were calculated from the regression equation.
LLOQ was defined as the smallest amount of the analyte that could be measured in a sample with sufficient precision (± 20 %) and accuracy (range 80 -120 %) [1] . Precision and accuracy (i.e., ratio of mean actual concentration : theoretical concertration expressed as a percentage) were evaluated on three different days by determining the analytes in five replicates of test samples at nominal concentrations of 2.0, 10.0 and 80.0 ng/ml for curcumin, and 2.0, 30.0 and 500.0 ng/ml for piperine. A standard calibration curve was prepared and processed each day to analyse the test samples.
The precision of the method at each concentration was reported as coefficient of variation (CV %), i.e., expressing standard deviation as a percentage of the mean calculated concentration, while the accuracy of the measure was determined by expressing the mean calculated concentration as percentage of the nominal concentration.
Extraction recovery (%) of the two analytes was determined in five replicates and at three plasma concentrations of the test samples, and estimated by comparing peak-area ratios of both analytes from extracted plasma samples to those from prepared standards.
Plasma matrix effect was tested by comparing the chromatographic peak areas from neat standards and blank plasma extracts spiked with neat standards at three concentrations of test samples for curcumin and piperine. The stability of the compounds was evaluated by analysing test samples in triplicate at each concentration level, immediately after preparation and after leaving 12 h at room temperature or after three freeze-thaw cycles in plasma, as well as after approximately 2 months of storage at −70 0 C, In each case, the analytes were quantified in the stored samples using a freshly prepared calibration curve.
During all the operations, samples were protected from light due to the susceptibility of curcumin and piperine to photodegradation [Error! Bookmark not defined.,1].
Human studies
Nine healthy Chinese volunteers were recruited. The study was approved by the Ethics Committee of the Second Xiangya Hospital of Central South University (Changsha, China) and informed consent was obtained from all subjects. The volunteers were instructed not to take any drug one week before and during the trials. On the trial day, after an 8 h overnight fast, 600 mg of curcumin plus 20 mg of piperine were co-administered and blood samples drawn at 0, 0.25, 0.5, 1, 2, 4, 6, 8, 12, 24, 36, 48 and 60 h after dosing. Each blood sample was collected in a heparinized tube and immediately centrifuged. The separated plasma was stored frozen at −70 0 C until analyzed.
Data analysis
Data are reported as mean ± standard deviation (SD) for the replicates. The CV (or RSD) values and accuracy were calculated using Microsoft Excel 2003.
RESULTS
LC-ESI-MS/MS analyses
The analytes were detected in positive ionization mode by monitoring their sample taken 6 h after oral administration of the drugs (C).
Calibration curves and LLOQ
LLOQ, or sensitivity, is defined as the lowest concentration on the standard curve that can be measured with acceptable precision (≤ 20 %) and accuracy (≤ 20 % of the nominal value) [18] . Based on this method, LLOQ for curcumin and piperine were 1.0 and 0.5 ng/ml, respectively.
The calibration curves showed good linearity and acceptable data over a wide range of concentrations (1.0 -100.0 ng/ml for curcumin, and 0.50 -800.0 ng/ml for piperine), with regression coefficient (R 2 ) ≥ 0.998. Mean accuracy was in the range 81.3 -119.9 % (at LLOQ) for curcumin and between 98.1 and 116.6 % for piperine. Precision, expressed as CV %, was in the range 2.91 -13.10 % for curcumin and 0.51 -11.21 % for piperine.
Precision and accuracy
The accuracy and precision for the analytes are shown in Table 1 . The method was precise and accurate, with intra-and interday CV ≤ 12.36 % and accuracy in the range of 94.40 -108.36 % for curcumin and 94.60 -103.82 % for piperine.
Matrix effect
The results show that the peak area ratio of spiked plasma sample to their corresponding neat solution ranged from 101.99 to 106.81% for both compounds.
Recovery
Mean extraction recovery for curcumin at 2.0, 10.0 and 80.0 ng/ml was ≥ 85.6 %, with good reproducibility indicated by CV% in the range 2.44 -6.86 %. Recovery of piperine at 2.0, 30.0 and 500.0 ng/ml was > 87.4 % with reproducibility expressed as CV ≤ 7.45 %. 
Short-term stability at room temperature
We evaluated short-term stability in this study where three aliquots of each test sample were left at room temperature and analysed after 12 h. This short-term stability experiment revealed no significant degradation for the two compounds in human plasma when left at room temperature over a period of 12 h, with CV of 2.77 -6.20 % for curcumin and 2.14 -4.85 % for piperine.
Plasma sample freeze-thaw stability
The results indicate that both curcumin and piperine were stable in plasma after three freeze-thaw cycles, with CV of 1.64 -6.12 % for curcumin and 1.77 -5.24 % for piperine. 
Long
DISCUSSION
A sensitive and reliable LC-MS/MS method has been developed for the determination of curcumin and piperine in human plasma. The specificity of the extraction indicate that the chromatographic method tested possessed the capacity to differentiate and quantitate the analyte in the presence of other endogenous constituents in samples, as well as to detect potential interferences. The analytical procedure used was based on liquid-liquid extraction to obtain sufficiently high recoveries. Significantly lower limit of quantitation was achieved in plasma compared to previously published methods [9, 16] , with LLOQ as low as 1.0 ng/ml for curcumin and 0.5 ng/ml for piperine. No interfering peaks were observed and no significant peaks were found at the retention times of the analytes using the LLE step for both analytes.
Since plasma is a complex biological matrix, any other endogenous compounds which coelute with the analytes may cause ion suppression or enhancement, which in turn makes the quantitation of the analytes inaccurate [3, 4] . In the present study, plasma matrix effect was tested by comparing chromatographic peak areas from neat standards and blank plasma extracts spiked with neat standards at concentrations of the test samples of the two compounds. The results obtained showed that the matrix effect of the plasma extract was insignificant.
CONCLUSION
The HPLC-MS/MS technique presented in this work for the simultaneous determination of curcumin and piperine in human plasma is highly selective and rugged for routine measurement of these drugs in combination therapy. The results of this study indicate that the method would be applicable to toxicokinetic, pharmacokinetic, bioavailability, and bioequivalence studies.
